Screener
Evommune EVMN Q1 2026 earnings
Reported May 7, 2026 · Before market open
EPS-$0.64Beat by $0.19
Revenue estimate$722.2K
EPS estimate-$0.83
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
Q3 2026-$0.85Miss by $0.02Q2 2026-$0.89Miss by $0.23
Q1 2026-$0.64Beat by $0.19
Q4 2025-$1.43Miss by $0.61Q3 2025-$8.07Miss by $1.99FAQ
- When did Evommune report Q1 2026 earnings?
- Evommune (EVMN) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Evommune's Q1 2026 revenue and EPS?
- Evommune reported eps of $-0.64 for Q1 2026.
- Did Evommune beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.83 by $0.19.
- Where can I find Evommune's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-211934) and the 10-Q periodic report (0001193125-26-211963) directly on SEC EDGAR. The filing index links above go to sec.gov.
